Ozempic and Wegovy still account for the dominant share of GLP-1 prescriptions in 2026 and will continue to do so for several years
If a pharmacy has not conducted sterility testing and stability studies on a particular formulation, USP 797 provides default BUD limits that are quite conservative, often just 14 days or less for certain preparation categories
By combining observed treatment responses (weight loss, biomarker shifts, appetite changes) with genetic predisposition insights, you and your provider can make more informed decisions about dosing adjustments, formulation choice (injection vs
This guide gives you the complete diagnostic framework for B12 deficiency which tests to run, what the numbers actually mean, whos most at risk, and what to do at each stage of deficiency
Available from: Brittany V B Johnson 1 , Mary Milstead 1 , Rachel Kreider 1 , Rachel Jones 1 Dietary supplement considerations during glucagon-like Peptide-1 receptor agonist treatment: A narrative review